4.5 Article

Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures

Journal

CLINICAL GENETICS
Volume 101, Issue 1, Pages 87-100

Publisher

WILEY
DOI: 10.1111/cge.14074

Keywords

22q13 deletion syndrome; Phelan-McDermid syndrome; PMS; seizure; SHANK3

Funding

  1. Clemson University Support for Early Exploration and Development (CU SEED) Grant Program
  2. Greenwood Genetic Center Foundation [0005]
  3. Hope for 22q13 Gala
  4. South Carolina Department of Special Needs and Disabilities

Ask authors/readers for more resources

This study investigated the prevalence of seizures and their association with genetic and metabolic features in Phelan-McDermid syndrome (PMS) patients. Results showed that individuals with pathogenic SHANK3 mutations had the highest prevalence of seizures, and the gene TBC1D22A in the 22q13.31 region was significantly associated with seizure prevalence. Additionally, a distinct metabolic profile was identified for PMS patients with seizures, indicating a disrupted utilization of main energy sources.
Phelan-McDermid syndrome (PMS) (OMIM*606232) is a rare genetic disorder characterized by intellectual disability, autistic features, speech delay, minor dysmorphia, and seizures. This study was conducted to investigate the prevalence of seizures and the association with genetic and metabolic features since there has been little research related to seizures in PMS. For 57 individuals, seizure data was collected from caregiver interviews, genetic data from existing cytogenetic records and Sanger sequencing for nine 22q13 genes, and metabolic profiling from the Phenotype Mammalian MicroArray (PM-M) developed by Biolog. Results showed that 46% of individuals had seizures with the most common type being absence and grand-mal seizures. Seizures were most prevalent in individuals with pathogenic SHANK3 mutations (70%), those with deletion sizes >4 Mb (16%), and those with deletion sizes <4 Mb (71%) suggesting involvement of genes in addition to SHANK3. Additionally, a 3 Mb genomic region on 22q13.31 containing the gene TBC1D22A, was found to be significantly associated with seizure prevalence. A distinct metabolic profile was identified for individuals with PMS with seizures and suggested among other features a disrupted utilization of main energy sources using Biolog plates. The results of this study will be helpful for clinicians and families in anticipating seizures in these children and for researchers to identify candidate genes for the seizure phenotype.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available